LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 59.42 | 21.74 | 5536 | 6125 | 0.9038 | 0.9753 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.39 | 21.74 | 476 | 6112 | 0.0779 | 0.4614 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.39 | 21.74 | 5790 | 6112 | 0.9472 | 0.9867 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.39 | 21.74 | 2884 | 6112 | 0.4718 | 0.8236 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 62.39 | 21.74 | 5755 | 6112 | 0.9415 | 0.9852 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.36 | 21.74 | 487 | 6191 | 0.0787 | 0.4642 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.36 | 21.74 | 6143 | 6191 | 0.9923 | 0.9981 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.36 | 21.74 | 2905 | 6191 | 0.4692 | 0.8228 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 64.36 | 21.74 | 6005 | 6191 | 0.9700 | 0.9925 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.33 | 21.74 | 524 | 6235 | 0.0840 | 0.4767 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.33 | 21.74 | 6231 | 6235 | 0.9993 | 0.9998 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.33 | 21.74 | 2664 | 6235 | 0.4272 | 0.8022 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 66.33 | 21.74 | 6276 | 6235 | 1.0065 | 1.0016 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.30 | 21.74 | 562 | 6244 | 0.0900 | 0.4893 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.30 | 21.74 | 6509 | 6244 | 1.0423 | 1.0102 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.30 | 21.74 | 2377 | 6244 | 0.3807 | 0.7769 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 68.30 | 21.74 | 6596 | 6244 | 1.0563 | 1.0135 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.27 | 21.74 | 466 | 6201 | 0.0751 | 0.4561 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.27 | 21.74 | 6953 | 6201 | 1.1211 | 1.0282 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.27 | 21.74 | 1596 | 6201 | 0.2573 | 0.6934 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 70.27 | 21.74 | 6828 | 6201 | 1.1009 | 1.0237 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.24 | 21.74 | 473 | 6162 | 0.0768 | 0.4594 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.24 | 21.74 | 7141 | 6162 | 1.1589 | 1.0365 | MN20160310_N01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.24 | 21.74 | 1216 | 6162 | 0.1973 | 0.6388 | MN20160310_N01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 72.24 | 21.74 | 7048 | 6162 | 1.1438 | 1.0333 | MN20160310_N01 | E11 |